載入...
Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidence
Progress in the treatment of patients with advanced stage squamous cell non-small cell lung cancer (NSCLC) has been limited. An improvement in the understanding of tumor immunosurveillance has resulted in the development of the immune checkpoint inhibitors such as nivolumab. Nivolumab (Opdivo(®)), a...
Na minha lista:
| 發表在: | Ther Adv Respir Dis |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933620/ https://ncbi.nlm.nih.gov/pubmed/27480166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465816661091 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|